Allied Market Research


Pet Noise Anxiety Market

Pet Noise Anxiety Market Size, Share, Competitive Landscape and Trend Analysis Report by Drug Type, by End User and by Medication Type : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Dogs have stronger hearing sense compared to humans. They are more sensitive to noise. They suffer from noise aversion, which is sensitivity to loud noises and leads to fear and sometimes anxiety. Sileo has been approved by the FDA to help in the treatment of noise aversion. It is a dexmedetomidine oromucosal gel, and is only available if there is a prescription available by the veterinarian.


Symptoms for noise aversion in dogs include panting, shaking, acting restlessly, trembling, escaping and running all the way, seeking out people, not eating food or refusing to eat, bolting, vomiting or excessive drooling, and defecating or urinating all over the place.

COVID-19 scenario analysis:

  • Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. 
  • Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs, such as hydroxychloroquine, have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs as many developed countries are short of these drugs. 
  • The pharmaceutical and biotechnology industries are expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19.
  • Attributed to such factors, COVID 19 is expected to have a significant impact on the pet noise anxiety market.

Top impacting factors: Market scenario analysis, trends, drivers and impact analysis

Increase in frequency in the adoption rates of pets in developed as well as developing economies, rise in disposable income, and the owners being ready to spend on their pets & animals are the major factors propelling the growth of the pet noise anxiety market. There has also been significant rise in veterinary doctors in both the underdeveloped and developed countries that drive the growth of the pet noise anxiety market. Rise in R&D activities and other advances in therapies and drugs also affect the growth of the pet noise anxiety market positively.

On the other hand, less awareness is observed amongst pet owners in regards to the pet noise anxiety disorders, which is the major challenge faced by the pet noise anxiety market.

New product launches and acquisitions to boost the market:

On December 4th, 2018, the U.S. Food and Drug Administration approved Pexion tablets commonly known as Imepitoin by the Center for Veterinary Medicine, which help in the treatment of noise aversion in dogs. On June 29th, 2018, FDA issued a second warning for overdosing of Sileo to dogs, owing to the mechanism of the ring-stop, which does not lock the intended dose. During this period, FDA and Zoetis worked together on the instruction manual for the prevention of overdose. During this process, Zoetis worked upon various programs such as training videos, guiding the staff, and the pet owners on handling the product and applying it to the pets. Despite the measures taken, the problem wasn’t solved and the FDA encountered new 34 reports of overdoses in dogs even after the after the June 2018 warning. 

Surge in usage in veterinary hospital applications:

Veterinary clinics, hospitals, pharmacies, and drug stores are the major consumers of the pet noise anxiety market. Amongst them, veterinary hospitals are the biggest end users in the market. This is due to the rise in prescription of drugs as the adoption rate is going up for pets.

Key benefits of the report:

  • This study presents the analytical depiction of the pet noise anxiety market along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the pet noise anxiety market share.
  • The current market is quantitatively analyzed to highlight the pet noise anxiety market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
  • The report provides a detailed analysis based on competitive intensity and how the competition will take shape in coming years.

Questions answered in the pet noise anxiety market research report:

  • Which are the leading market players active in the pet noise anxiety market?
  • What are the current trends that will influence the pet noise anxiety market in the next few years?
  • What are the driving factors, restraints, and opportunities of the pet noise anxiety market?
  • What are the projections for the future that would help in taking further strategic steps?

Pet Noise Anxiety Market Report Highlights

Aspects Details
By Drug Type
  • Alprazolam
  • Amitriptyline
  • Buspirone
  • Clomipramine
  • Dexmedetomidine
  • Diazepam
  • Others
By End User
  • Veterinary Hospitals
  • Veterinary Clinics
  • Pharmacies & Drug Stores
  • Others
By Medication Type
  • Oral Type
  • Smear Type
  • Injection Type
By Region
  • North America  (US, Canada)
  • Europe  (Germany, UK, France, rest of Europe)
  • Asia-Pacific  (China, Japan, India, rest of Asia-Pacific)
  • Latin America  (Brazil, Mexico, rest of LATAM)
  • the Middle East 
  • Africa 
Key Market Players

Merck & Co., Inc, Zoetis, Vets4Pets Limited, Angelini Pharma Inc, Physicians Total Care, Inc., Glaxo Smith Kline, Pegasus Laboratories, Inc., Pfizer Limited, Adaptil

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Pet Noise Anxiety Market

Global Opportunity Analysis and Industry Forecast, 2023-2032